Will Mifepristone Prove a CATALYST for Change?
Treatment with mifepristone results in clinically meaningful improvements in HbA1c and cardiometabolic risk in patients with difficult-to-control T2D and hypercortisolism.Medscape Diabetes & Endocrinology
Read more »